Exhibit 99.3
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
On April 17, 2008, we completed the acquisition of Advanced Medical Partners, Inc. (“AMPI”) pursuant to the Stock Purchase Agreement dated March 18, 2008 between us, Litho Management, Inc., AMPI and the stockholders of AMPI. We acquired the outstanding shares of capital stock of AMPI (other than shares already held by us) for a purchase price of approximately $6.9 million in cash and approximately 1.8 million shares of common stock, plus a two-year earn-out based on the future achievement of EBITDA.
The following unaudited pro forma condensed combined financial information presents the combined historical consolidated statements of operations and consolidated balance sheet of HealthTronics, Inc. and the historical combined statements of operations and combined balance sheet of AMPI to reflect our acquisition of AMPI (the “Acquisition”). The historical financial statements were prepared in conformity with accounting principles generally accepted in the United States of America. The unaudited pro forma condensed combined financial information is presented in accordance with the rules specified by Article 11 of Regulation S-X promulgated by the Securities and Exchange Commission, and has been prepared using the assumptions described in the notes thereto. The unaudited pro forma condensed combined balance sheet gives effect to the Acquisition as if it had occurred as of the balance sheet date. The unaudited pro forma condensed combined statements of operations give effect to the Acquisition as if it had occurred as of January 1, 2007.
The following unaudited pro forma condensed combined financial information is presented:
| • | | Unaudited pro forma condensed combined balance sheet of HealthTronics as of March 31, 2008; |
| • | | Unaudited pro forma condensed combined statement of operations of HealthTronics for the three months ended March 31, 2008; and |
| • | | Unaudited pro forma condensed combined statement of operations of HealthTronics for the year ended December 31, 2007. |
The unaudited pro forma condensed combined financial information should be read in conjunction with the notes thereto and the historical combined financial statements of AMPI, including the notes thereto, which were filed as an exhibit to HealthTronics’s Current Report on Form 8-K/A dated as of and filed on June 30, 2008, as well as in conjunction with HealthTronics’s historical consolidated financial statements included in its Annual Report on Form 10-K for the year ended December 31, 2007 and its Quarterly Report on Form 10-Q for the three months ended March 31, 2008.
The unaudited pro forma condensed combined financial information is presented for informational purposes only and is not necessarily indicative of the financial position or results of operations of the combined company. The unaudited pro forma condensed combined financial information does not give effect to any potential cost savings or other operational efficiencies that could result from the Acquisition.
HEALTHTRONICS, INC. AND SUBSIDIARIES
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
AS OF MARCH 31, 2008
| | | | | | | | | | | | | | | | |
($ in thousands) | | HealthTronics | | | AMPI | | | Pro Forma Adjustments | | | Pro Forma Combined | |
ASSETS | | | | | | | | | | | | | | | | |
| | | | |
Current assets: | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 21,707 | | | $ | 1,726 | | | $ | (7,840 | )(1) | | $ | 15,535 | |
| | | | | | | | | | | (58 | )(1) | | | | |
Accounts receivable, net | | | 19,996 | | | | 3,871 | | | | | | | | 23,867 | |
Other receivables | | | 2,083 | | | | 92 | | | | | | | | 2,175 | |
Deferred income taxes | | | 12,829 | | | | (87 | ) | | | | | | | 12,742 | |
Prepaid expenses and other current assets | | | 2,527 | | | | 36 | | | | | | | | 2,563 | |
Inventory | | | 9,276 | | | | 2,182 | | | | | | | | 11,458 | |
| | | | | | | | | | | | | | | | |
Total current assets | | | 68,418 | | | | 7,820 | | | | (7,898 | ) | | | 68,340 | |
| | | | | | | | | | | | | | | | |
Property and equipment: | | | | | | | | | | | | | | | | |
Equipment, furniture and fixtures | | | 48,539 | | | | 6,991 | | | | (3,338 | )(2) | | | 52,192 | |
Building and leasehold improvements | | | 12,942 | | | | 17 | | | | | | | | 12,959 | |
| | | | | | | | | | | | | | | | |
| | | 61,481 | | | | 7,008 | | | | (3,338 | ) | | | 65,151 | |
Less accumulated depreciation and amortization | | | (27,376 | ) | | | (3,338 | ) | | | 3,338 | (2) | | | (27,376 | ) |
| | | | | | | | | | | | | | | | |
Property and equipment, net | | | 34,105 | | | | 3,670 | | | | — | | | | 37,775 | |
| | | | | | | | | | | | | | | | |
Other investments | | | 1,353 | | | | 204 | | | | | | | | 1,557 | |
Goodwill, at cost | | | 218,020 | | | | 765 | | | | (765 | )(3) | | | 229,972 | |
| | | | | | | | | | | 11,952 | (3) | | | | |
Intangible assets | | | 6,014 | | | | — | | | | | | | | 6,014 | |
Other noncurrent assets | | | 4,918 | | | | 350 | | | | | | | | 5,268 | |
| | | | | | | | | | | | | | | | |
| | $ | 332,828 | | | $ | 12,809 | | | $ | 3,289 | | | $ | 348,926 | |
| | | | | | | | | | | | | | | | |
LIABILITIES | | | | | | | | | | | | | | | | |
| | | | |
Current liabilities: | | | | | | | | | | | | | | | | |
Current portion of long-term debt | | $ | 4,057 | | | $ | 558 | | | | | | | $ | 4,615 | |
Accounts payable | | | 6,877 | | | | 2,146 | | | | | | | | 9,023 | |
Accrued distributions to minority interests | | | 95 | | | | — | | | | | | | | 95 | |
Accrued expenses | | | 5,284 | | | | 418 | | | | | | | | 5,702 | |
| | | | | | | | | | | | | | | | |
Total current liabilities | | | 16,313 | | | | 3,122 | | | | — | | | | 19,435 | |
| | | | |
Long-term debt, net of current portion | | | 3,777 | | | | 1,145 | | | | (540 | )(4) | | | 4,382 | |
Other long term obligations | | | 53 | | | | — | | | | | | | | 53 | |
Deferred income taxes | | | 30,679 | | | | 260 | | | | | | | | 30,939 | |
| | | | | | | | | | | | | | | | |
Total liabilities | | | 50,822 | | | | 4,527 | | | | (540 | ) | | | 54,809 | |
| | | | |
Minority interest | | | 38,713 | | | | 5,373 | | | | | | | | 44,086 | |
| | | | |
STOCKHOLDERS’ EQUITY | | | | | | | | | | | | | | | | |
| | | | |
Common stock, no par value | | | 202,472 | | | | 1 | | | | (1 | )(3) | | | 209,210 | |
| | | | | | | | | | | 6,198 | (3) | | | | |
| | | | | | | | | | | 540 | (4) | | | | |
Additional paid-in capital | | | — | | | | 2,780 | | | | (2,780 | )(3) | | | — | |
Accumulated earnings | | | 41,293 | | | | 128 | | | | (128 | )(3) | | | 41,293 | |
Treasury stock, at cost | | | (472 | ) | | | — | | | | | | | | (472 | ) |
| | | | | | | | | | | | | | | | |
Total stockholders’ equity | | | 243,293 | | | | 2,909 | | | | 3,829 | | | | 250,031 | |
| | | | | | | | | | | | | | | | |
| | $ | 332,828 | | | $ | 12,809 | | | $ | 3,289 | | | $ | 348,926 | |
| | | | | | | | | | | | | | | | |
(1) | To reduce cash for monies paid for the acquisition and related transaction costs. |
(2) | To eliminate the accumulated depreciation of AMPI. |
(3) | To record the preliminary purchase price allocation arising from the acquisition of AMPI by HealthTronics as of December 31, 2007. The acquisition agreement was entered into on March 18, 2008. The calculation is based on cash paid and expenses incurred and the average market value of HealthTronics common stock for the period of two business days before and after the announcement date ($3.426 per share). |
| | | | | | | | |
Purchase price value of the 1,808,917 shares of HealthTronics common stock issued at $3.426 per share | | | | | | $ | 6,198,000 | |
Cash paid for the acquisition | | | | | | | 7,840,000 | |
| | | | | | | | |
| | | | | | | 14,038,000 | |
Net tangible assets acquired: | | | | | | | | |
Tangible assets acquired | | $ | (12,809,000 | ) | | | | |
Elimination of AMPI existing Goodwill | | | 765,000 | | | | | |
Net tangible liabilities and minority interest acquired | | | 9,900,000 | | | | | |
| | | | | | | | |
| | | | | | | (2,144,000 | ) |
Transaction costs incurred by HealthTronics for expenses paid relating to the acquisition | | | | | | | 58,000 | |
| | | | | | | | |
Excess purchase price over the fair value of AMPI net assets acquired | | | | | | | | |
| | | | | | | | |
(goodwill) based upon preliminary purchase price allocations | | | | | | $ | 11,952,000 | |
| | | | | | | | |
(4) | To eliminate notes payable that were retired per terms of the acquisition utilizing Healthtronics common stock with an agreed upon price of $3.02. |
HEALTHTRONICS, INC. AND SUBSIDIARIES
UNAUDITED PROFORMA CONDENSED CONSOLIDATED STATEMENTS OF INCOME
FOR THE YEAR ENDED DECEMBER 31, 2007
($ in thousands, except per share data)
| | | | | | | | | | | | | | | | |
| | HealthTronics | | | AMPI | | | Pro Forma Adjustments | | | Pro Forma Combined | |
Revenue: | | | | | | | | | | | | | | | | |
Urology Services | | $ | 122,736 | | | $ | 24,728 | | | $ | (59 | )(1) | | $ | 147,405 | |
Medical Products | | | 17,101 | | | | — | | | | (157 | )(2) | | | 16,944 | |
Other | | | 581 | | | | — | | | | | | | | 581 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 140,418 | | | | 24,728 | | | | (216 | ) | | | 164,930 | |
| | | | | | | | | | | | | | | | |
Cost of services and general and administrative expenses: | | | | | | | | | | | | | | | | |
Urology Services | | | 53,490 | | | | 11,681 | | | | (157 | )(2) | | | 65,014 | |
Medical Products | | | 11,225 | | | | — | | | | | | | | 11,225 | |
Selling, general and administrative | | | 15,884 | | | | 5,346 | | | | | | | | 21,230 | |
Impairment charges | | | 20,800 | | | | — | | | | | | | | 20,800 | |
Depreciation and amortization | | | 11,107 | | | | 1,163 | | | | | | | | 12,270 | |
| | | | | | | | | | | | | | | | |
| | | 112,506 | | | | 18,190 | | | | (157 | ) | | | 130,539 | |
| | | | | | | | | | �� | | | | | | |
Operating income | | | 27,912 | | | | 6,538 | | | | (59 | ) | | | 34,391 | |
| | | | |
Other income (expenses): | | | | | | | | | | | | | | | | |
Interest and dividends | | | 1,146 | | | | — | | | | (355 | )(3) | | | 791 | |
Interest expense | | | (829 | ) | | | (72 | ) | | | 11 | (4) | | | (890 | ) |
| | | | | | | | | | | | | | | | |
| | | 317 | | | | (72 | ) | | | (344 | ) | | | (99 | ) |
| | | | | | | | | | | | | | | | |
Income from continuing operations before provision for income taxes and minority interest | | | 28,229 | | | | 6,466 | | | | (403 | ) | | | 34,292 | |
Minority interest in consolidated income | | | 45,568 | | | | 5,648 | | | | | | | | 51,216 | |
| | | | |
Provision (benefit) for income taxes | | | (2,854 | ) | | | 275 | | | | (155 | )(5) | | | (2,734 | ) |
| | | | | | | | | | | | | | | | |
Income from continuing operations | | | (14,485 | ) | | | 543 | | | | (248 | ) | | | (14,190 | ) |
| | | | |
Income (loss) from discontinued operations, net of tax | | | (147 | ) | | | — | | | | | | | | (147 | ) |
| | | | | | | | | | | | | | | | |
Net income (loss) | | $ | (14,632 | ) | | $ | 543 | | | $ | (248 | ) | | $ | (14,337 | ) |
| | | | | | | | | | | | | | | | |
Basic earnings per share: | | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | (0.41 | ) | | | | | | | | | | $ | (0.38 | ) |
Income (loss) from discontinued operations | | $ | — | | | | | | | | | | | $ | — | |
| | | | | | | | | | | | | | | | |
Net income (loss) | | $ | (0.41 | ) | | | | | | | | | | $ | (0.38 | ) |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding | | | 35,421 | | | | | | | | | | | | 37,409 | |
| | | | | | | | | | | | | | | | |
Diluted earnings per share: | | | | | | | | | | | | | | | | |
Income from continuing operations | | $ | (0.41 | ) | | | | | | | | | | $ | (0.38 | ) |
Income (loss) from discontinued operations | | $ | — | | | | | | | | | | | $ | — | |
| | | | | | | | | | | | | | | | |
Net income (loss) | | $ | (0.41 | ) | | | | | | | | | | $ | (0.38 | ) |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding | | | 35,421 | | | | | | | | | | | | 37,409 | |
| | | | | | | | | | | | | | | | |
(1) | To reduce equity income for distributions paid to HealthTronics by AMPI. |
(2) | To reduce revenue and cost of services for Revolix rental charges paid to HealthTronics by AMPI. |
(3) | To adjust interest income based on reduced cash balances due to acquisition costs using an interest rate of 4.5% which was the average rate earned on cash balances in 2007. |
(4) | To adjust interest expense on debt retired as part of the acquisition using an interest rate of 8% per the promissory notes. |
(5) | To record the income tax benefit of the pro forma adjustments using a rate of 38.5%. |
HEALTHTRONICS, INC. AND SUBSIDIARIES
UNAUDITED PROFORMA CONDENSED CONSOLIDATED STATEMENTS OF INCOME
FOR THE THREE MONTHS ENDED MARCH 31, 2008
($ in thousands, except per share data)
| | | | | | | | | | | | | | | | |
| | HealthTronics | | | AMPI | | | Pro Forma Adjustments | | | Pro Forma Combined | |
Revenue: | | | | | | | | | | | | | | | | |
Urology Services | | $ | 29,550 | | | $ | 7,357 | | | $ | (50 | )(1) | | $ | 36,857 | |
Medical Products | | | 4,247 | | | | — | | | | (262 | )(2) | | | 3,985 | |
Other | | | 157 | | | | — | | | | | | | | 157 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 33,954 | | | | 7,357 | | | | (312 | ) | | | 40,999 | |
| | | | | | | | | | | | | | | | |
Cost of services and general and administrative expenses: | | | | | | | | | | | | | | | | |
Urology Services | | | 12,991 | | | | 3,648 | | | | | | | | 16,639 | |
Medical Products | | | 2,177 | | | | — | | | | (262 | )(2) | | | 1,915 | |
Selling, general and administrative | | | 4,317 | | | | 1,148 | | | | | | | | 5,465 | |
Depreciation and amortization | | | 2,628 | | | | 291 | | | | | | | | 2,919 | |
| | | | | | | | | | | | | | | | |
| | | 22,113 | | | | 5,087 | | | | (262 | ) | | | 26,938 | |
| | | | | | | | | | | | | | | | |
Operating income | | | 11,841 | | | | 2,270 | | | | (50 | ) | | | 14,061 | |
| | | | |
Other income (expenses): | | | | | | | | | | | | | | | | |
Interest and dividends | | | 191 | | | | — | | | | (89 | )(3) | | | 102 | |
Interest expense | | | (163 | ) | | | (13 | ) | | | 11 | (4) | | | (165 | ) |
| | | | | | | | | | | | | | | | |
| | | 28 | | | | (13 | ) | | | (78 | ) | | | (63 | ) |
| | | | | | | | | | | | | | | | |
Income from continuing operations before provision for income taxes and minority interest | | | 11,869 | | | | 2,257 | | | | (128 | ) | | | 13,998 | |
| | | | |
Minority interest in consolidated income | | | 11,047 | | | | 1,648 | | | | | | | | 12,695 | |
| | | | |
Provision (benefit) for income taxes | | | 370 | | | | 253 | | | | (49 | )(5) | | | 574 | |
| | | | | | | | | | | | | | | | |
Net income (loss) | | $ | 452 | | | $ | 356 | | | $ | (79 | ) | | $ | 729 | |
| | | | | | | | | | | | | | | | |
Basic earnings per share: | | | | | | | | | | | | | | | | |
Net income | | $ | 0.01 | | | | | | | | | | | $ | 0.02 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding | | | 35,425 | | | | | | | | | | | | 37,413 | |
| | | | | | | | | | | | | | | | |
Diluted earnings per share: | | | | | | | | | | | | | | | | |
Net income | | $ | 0.01 | | | | | | | | | | | $ | 0.02 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding | | | 35,425 | | | | | | | | | | | | 37,413 | |
| | | | | | | | | | | | | | | | |
(1) | To reduce equity income for distributions paid to HealthTronics by AMPI. |
(2) | To reduce revenue and cost of services for Revolix rental charges paid to HealthTronics by AMPI. |
(3) | To adjust interest income based on reduced cash balances due to acquisition costs using an interest rate of 4.5% which was the average rate earned on cash balances in 2008. |
(4) | To adjust interest expense on debt retired as part of the acquisition using an interest rate of 8% per the promissory notes. |
(5) | To record the income tax benefit of the pro forma adjustments using a rate of 38.5%. |